Mammary intra-arterial calcification (MIAC) was seen on the mammograms of 13 of 150 (8.7%) known diabetic patients and 21 of 300 (7.0%) age-matched control patients. Statistical analysis verified no significant difference between the rate of occurrence of MIAC in the diabetic group of patients and the control group. Therefore, contrary to previous reported studies, our study does not support the conclusion of an increased frequency of MIAC in diabetic patients. MIAC is a manifestation of peripheral vascular disease resulting from a variety of causes, one of which may be diabetes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00007611-198512000-00010 | DOI Listing |
Cancers (Basel)
November 2024
Department Surgical Oncology, Medias Klinikum, 84489 Burghausen, Germany.
Background: Relapsed unresectable triple-negative breast cancer is a demanding disease with only a few treatment options. Especially for patients with unresectable tumor masses, a treatment that offers rapid tumor shrinkage is needed. If patients are exhausted from several treatment lines, systemic side effects have to be avoided.
View Article and Find Full Text PDFCureus
April 2024
Internal Medicine, Wellington Regional Medical Center, Wellington, USA.
Breast cancer is a common malignancy in women, and the survival rate for this cancer is low once it metastasized. Currently, chemotherapy is the first-line treatment for metastatic breast cancer (MBC). However, when liver metastases (LM) are present, the response to chemotherapy is poor.
View Article and Find Full Text PDFPLoS One
May 2024
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Purpose: To investigate the treatment efficacy of intra-arterial (IA) trastuzumab treatment using multiparametric magnetic resonance imaging (MRI) in a human breast cancer xenograft model.
Materials And Methods: Human breast cancer cells (BT474) were stereotaxically injected into the brains of nude mice to obtain a xenograft model. The mice were divided into four groups and subjected to different treatments (IA treatment [IA-T], intravenous treatment [IV-T], IA saline injection [IA-S], and the sham control group).
J Vasc Interv Radiol
April 2024
Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Purpose: To assess the treatment response to transarterial chemotherapy followed by chemoembolization for locally recurrent breast cancer.
Materials And Methods: Thirty-nine women with locally recurrent breast cancer after standard therapy underwent selective intra-arterial chemotherapy followed by embolization using drug-eluting microspheres for locally recurrent tumors and axillary lymph node metastases. Tumor response and toxicity were assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) and Common Terminology Criteria for Adverse Events (CTCAE), and survival was evaluated by the Kaplan‒Meier method.
J Med Imaging Radiat Oncol
December 2023
IRCCS Istituto Europeo di Oncologia, Milan, Italy.
Breast cancer (BC) is the most common cancer and one of the most important causes of death in women. Surgery is the standard therapy for breast cancer and in the last decades evolved towards a more conservative approach, with lumpectomy, followed by radiation therapy, the most common option. Unfortunately, up to 40% of women affected by BC will develop metastases and will receive systemic therapy, which improves survival and quality of life.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!